Healsun Biopharm

About:

Healsun Biopharm is a Biopharmaceutical company that focuses on antibody/recombinant protein CRO/CDMO

Website: http://www.hs-biopharm.com

Top Investors: Shanghai Biomedical Industrial Equity Investment Fund, Yinxinggu Capital, Haitong Capital, Haibang Capital, Dongfang Jiafu

Description:

Healsun Biopharm is a high-tech antibody/recombinant protein CRO/CDMO company, offering end-to-end service by multiple platforms from early developability assessments, stable cell line construction, culture medium customization, process development (including ADC), to pilot production, IND application and clinical production.

Total Funding Amount:

705M CNY

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2015-01-01

Contact Email:

Postmaster(AT)hs-biopharm.com

Founders:

Yuliang Huang

Number of Employees:

251-500

Last Funding Date:

2023-10-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai